MediWound (MDWD) Gains from Investment Securities (2017 - 2024)
MediWound (MDWD) posted quarterly Gains from Investment Securities of -$27000.0 for Q4 2024, up 92.17% year-over-year from -$14049.8 in Q1 2024, and down 575.0% quarter-over-quarter from -$4000.0 in Q3 2024.
MediWound (MDWD) Gains from Investment Securities (2017 - 2024) Analysis & Trends
MediWound's Gains from Investment Securities history runs 8 years deep, the most recent figure standing at -$27000.0 for Q4 2024.
- In Q4 2024, Gains from Investment Securities rose 92.17% year-over-year to -$27000.0; the TTM figure through Dec 2024 stood at -$308000.0 (down 10.0% YoY), while the FY2024 annual figure was $47000.0, down 75.13% from the prior year.
- Gains from Investment Securities for Q4 2024 stood at -$27000.0, down from -$4000.0 in the prior quarter.
- The five-year high for Gains from Investment Securities was $283000.0 in Q2 2022, with the low at -$482000.0 in Q2 2021.
- The 5-year median for Gains from Investment Securities is -$4000.0 (2024), against an average of -$10538.5.
- Peak annual rise in Gains from Investment Securities reached 224.05% in 2021, while the deepest fall reached 845.1% in 2021.
- MediWound's Gains from Investment Securities stood at -$51000.0 in 2020, then jumped by 298.04% to $101000.0 in 2021, then tumbled by 40.59% to $60000.0 in 2022, then plunged by 675.0% to -$345000.0 in 2023, then surged by 92.17% to -$27000.0 in 2024.
- Business Quant data shows MDWD's Gains from Investment Securities at -$27000.0 in Q4 2024, -$4000.0 in Q3 2024, and -$345000.0 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | MediWound | 170.65 Mn | 139.65 Mn | 337,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -27,000.00 |
| Dec 31, 2024 | -27,000.00 |
| Sep 30, 2024 | -4,000.00 |
| Sep 30, 2024 | -4,000.00 |
| Dec 31, 2023 | -345,000.00 |
| Dec 31, 2023 | -345,000.00 |
| Sep 30, 2023 | 68,000.00 |
| Sep 30, 2023 | 68,000.00 |
| Dec 31, 2022 | 60,000.00 |
| Dec 31, 2022 | 60,000.00 |
| Sep 30, 2022 | -63,000.00 |
| Sep 30, 2022 | -63,000.00 |
| Jun 30, 2022 | 283,000.00 |
| Jun 30, 2022 | 283,000.00 |
| Dec 31, 2021 | 101,000.00 |
| Dec 31, 2021 | 101,000.00 |
| Sep 30, 2021 | -12,000.00 |
| Sep 30, 2021 | -12,000.00 |
| Jun 30, 2021 | -482,000.00 |
| Jun 30, 2021 | -482,000.00 |